Comparative effectiveness and safety outcomes between denosumab and bisphosphonate in South Korea

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study2015 · 277 citations
2. 2Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation2019 · 36 citations
3. 3Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women2008 · 406 citations
4. 4Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials2023 · 214 citations
5. 5Oral Bisphosphonates Are Associated With Increased Risk of Severe Acute Kidney Injury in Elderly Patients With Complex Health Needs: A Self-Controlled Case Series in the United Kingdom2020 · 17 citations